ALYSSA SILADIE: Open Payments
NPI 1396014502 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,085 in 163 payments from 45 companies in 2025. Trend: 2023 $3,088 · 2024 $2,747 · 2025 $4,085
Food & beverage: $4,085
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $527 |
| Janssen Biotech, Inc. | 18 | $437 |
| Daiichi Sankyo Inc. | 10 | $271 |
| Novartis Pharmaceuticals Corporation | 10 | $257 |
| Merck Sharp & Dohme LLC | 8 | $215 |
| PFIZER INC. | 9 | $196 |
| Regeneron Healthcare Solutions, Inc. | 6 | $182 |
| GlaxoSmithKline, LLC. | 6 | $160 |
| Gilead Sciences, Inc. | 6 | $153 |
| Incyte Corporation | 6 | $152 |
Products named: Enhertu, CARVYKTI, LIBTAYO, Trodelvy, KEYTRUDA, OJJAARA, LUTATHERA, IMFINZI.
Industry payments across FL — which companies pay providers there.
